Patents by Inventor Akira Kikuchi

Akira Kikuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240329345
    Abstract: A core portion of each of optical fibers of an optical fiber cable is made of pure silica glass, an effective cross-sectional area of the core portion at a wavelength of 1550 nm is 110 ?m2 or more and 150 ?m2 or less. The optical fibers include an intermittent connection portion in which a connection portion to which an adhesive resin is applied and a non-connection portion to which the adhesive resin is not applied are alternately provided between adjacent optical fibers. The optical fiber ribbon has a ratio of a total adhesion length to which the adhesive resin is applied to a total length between all the optical fibers of 40% or more per a unit length of the optical fiber ribbon, and an occupancy ratio of the optical fiber ribbon to a cross-sectional area of the internal space is 30% or more and 40% or less.
    Type: Application
    Filed: August 24, 2022
    Publication date: October 3, 2024
    Inventors: Yutaka HASHIMOTO, Fumiaki SATO, Masashi KIKUCHI, Soichi ISHIKAWA, Akira SAKURAI, Yusuke YAMADA, Sadaharu HOMAN
  • Patent number: 12108690
    Abstract: A quantum device capable of securing terminals for external connection is provided. A quantum device according to an example embodiment includes a quantum chip 10, an interposer 20 on which the quantum chip 10 is mounted, and a socket 40 disposed so as to be opposed to the interposer 20, the socket 40 comprising a movable pin 47 and a housing 45 supporting the movable pin 47, in which at least one end of the movable pin 47, which includes the one end and the other end opposite to the one end, is movable relative to the housing 45, the one end being in electrical contact with a terminal of the interposer 20, and the other end is in an electrical contact with a terminal of a board 50 on which a connector 51 is formed, the connector 51 being configured to serve as an external input/output.
    Type: Grant
    Filed: June 15, 2021
    Date of Patent: October 1, 2024
    Assignee: NEC CORPORATION
    Inventors: Katsumi Kikuchi, Akira Miyata, Suguru Watanabe, Takanori Nishi, Hideyuki Satou, Kenji Nanba, Ayami Yamaguchi
  • Patent number: 12094812
    Abstract: A quantum device capable of improving a cooling effect while securing the number of terminals is provided. A quantum device according to an example embodiment includes a quantum chip 10, and an interposer 20 on which the quantum chip 10 is mounted, in which the interposer 20 includes a conductive wiring line CL1 electrically connected to the quantum chip 10, and a metal film 70 disposed in a part of the interposer 20 that is in contact with a sample stage 30 having a cooling function, and a mounting surface 21 of the interposer 20 on which the quantum chip 10 is mounted or an opposite surface 22 opposite to the mounting surface 21 includes a first area AR11 and a second area AR12 different from the first area AR11 as viewed in a direction perpendicular to the mounting surface 21 or the opposite surface 22.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: September 17, 2024
    Assignee: NEC CORPORATION
    Inventors: Katsumi Kikuchi, Akira Miyata, Suguru Watanabe, Takanori Nishi, Hideyuki Satou, Kenji Nanba, Ayami Yamaguchi
  • Publication number: 20240302620
    Abstract: An optical fiber cable according to the present disclosure includes a cable core having one or a plurality of optical fiber core wires therein; an outer cover which covers the cable core and has a concave portion or a plurality of convex portions for an outer edge of a cross section perpendicular to a long axis direction of the outer cover; and an impression which is marked on the concave portion or on a portion sandwiched between the plurality of convex portions of a side surface of the outer cover.
    Type: Application
    Filed: May 31, 2021
    Publication date: September 12, 2024
    Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATION
    Inventors: Masashi KIKUCHI, Shigekatsu TETSUTANI, Yusuke YAMADA, Akira SAKURAI, Hiroaki TANIOKA
  • Publication number: 20240288656
    Abstract: In order to achieve the foregoing object, the optical cable laying method of the present disclosure lays an optical cable on a road surface or a wall surface so that the optical cable passes through two points along a route therebetween longer than a minimum distance therebetween.
    Type: Application
    Filed: June 16, 2021
    Publication date: August 29, 2024
    Applicant: NIPPON TELEGRAPH AND TELEPONE CORPORATION
    Inventors: Akira SAKURAI, Hiroaki TANIOKA, Shigekatsu TETSUTANI, Yusuke YAMADA, Masashi KIKUCHI
  • Publication number: 20240288647
    Abstract: In order to achieve the above-mentioned object, an optical fiber cable according to the present disclosure includes an optical fiber core wire, a sheath covering the optical fiber core wire, three or more anti-tension members inside the sheath, arranged along a longitudinal axis of the optical fiber core wire, and a tear string having an outer periphery a part of which is located outside an outer circumscribed lines of outer peripheries of the three or more anti-tension members in certain cross-sections perpendicular to a longitudinal direction of the sheath, and a part of which comes in contact with an inner periphery of the sheath or is located inside the inner periphery of the sheath in a cross-section perpendicular to the longitudinal direction of the sheath.
    Type: Application
    Filed: June 18, 2021
    Publication date: August 29, 2024
    Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATION
    Inventors: Akira SAKURAI, Hiroaki TANIOKA, Shigekatsu TETSUTANI, Yusuke YAMADA, Masashi KIKUCHI
  • Patent number: 12071624
    Abstract: The purpose of the present invention is to provide an antisense oligonucleotide that targets an ARL4C molecule and exerts an antitumor effect in vivo, and a nucleic acid drug using the antisense oligonucleotide. An antisense oligonucleotide that has a base sequence consisting of at least 10 consecutive bases contained in the base sequence represented by SEQ ID NO: 1. This antisense oligonucleotide targets an ARL4C molecule and thus can inhibit the expression of ARL4C in a tumor cell in vitro and suppress the migration and proliferation thereof. When systemically administered, moreover, the antisense oligonucleotide can exert an excellent antitumor effect in vivo too.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: August 27, 2024
    Assignees: Osaka University, National Institutes of Biomedical Innovation, Health and Nutrition, National University Corporation Kobe University
    Inventors: Akira Kikuchi, Shinji Matsumoto, Satoshi Obika, Yuya Kasahara, Takumi Fukumoto
  • Publication number: 20240272394
    Abstract: An optical fiber cable according to the present disclosure includes: a cable core having a plurality of optical fiber core wires; a sheath covering the cable core; and at least two or more tension members, having warping ability outward from an axial center of a cable core, disposed inside the sheath along the cable core, and any one of the tension members is disposed at a position laying along a position of another of the tension members with the axial center of the cable core sandwiched between the positions.
    Type: Application
    Filed: May 31, 2021
    Publication date: August 15, 2024
    Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATION
    Inventors: Masashi KIKUCHI, Shigekatsu TETSUTANI, Yusuke YAMADA, Akira SAKURAI, Hiroaki TANIOKA
  • Publication number: 20240248001
    Abstract: An object of the present invention is to provide an optical fiber testing method and an optical fiber winding device capable of appropriately reproducing the same lateral pressure and minute bending state in a test of an optical fiber as those in an optical cable. In the optical fiber testing method according to the present invention, an optical fiber 51-2 of the second layer wound around a bobbin 12 is used as an object to be tested. Lateral pressure to the optical fiber 51-2 of the second layer is applied by an optical fiber 51-3 of the third layer. The lateral pressure is adjusted by a tension when the optical fiber 51-3 of the third layer is wound around the bobbin. In other words, since the lateral pressure is applied to the optical fiber to be tested from another optical fiber, the same lateral pressure and minute bending state as those in the optical cable can be reproduced.
    Type: Application
    Filed: May 31, 2021
    Publication date: July 25, 2024
    Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATION
    Inventors: Yusuke YAMADA, Masashi KIKUCHI, Akira SAKURAI, Shigekatsu TETSUTANI, Hiroaki TANIOKA
  • Patent number: 12037160
    Abstract: Provided are a packaging container, a packaging method, and a method for carrying metal foil, which can suppress damage and deformation of the packaging container and enable stable carrying even if the packaging container is carried while suspending it in the midair. A packaging container made of corrugated cardboard includes: a pallet 2 having leg portions 21; a body frame 3 arranged on the pallet 2, the body frame 3 having bearing grooves 31 at end wall portions 32 opposing to each other; and a lid portion 4 provided on the body frame 3, wherein each of the leg portions 21 is arranged on an inner side than each of the end wall portions 23 of the pallet 2.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: July 16, 2024
    Assignee: JX Advanced Metals Corporation
    Inventors: Akira Sako, Yasunobu Miyata, Kazuhiko Kikuchi
  • Patent number: 11942873
    Abstract: A secondary magnetic excitation generator-motor device that inputs a first ignition pulse command to a three-level NPC power converter such that a detected excitation current value corresponds with an excitation current command value, the secondary magnetic excitation generator-motor device having a function of identifying a first phase, a second phase, or a third phase in descending order of a current absolute value, wherein a pulse switch to output an ignition pulse command to the three-level NPC power converter switches the ignition pulse command to the second ignition pulse command when a current absolute value exceeds a set overcurrent level 1, and switches the ignition pulse command to the first ignition pulse command when current absolute values for three phases are all equal to or smaller than a set overcurrent level 2.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: March 26, 2024
    Assignees: HITACHI MITSUBISHI HYDRO CORPORATION, HITACHI, LTD.
    Inventors: Akira Bando, Hironari Kawazoe, Akira Kikuchi
  • Publication number: 20240039414
    Abstract: Provided is a power conversion device that can be realized with a small circuit and is capable of stably converting AC power inputted from a three-phase power source system into DC power. In a power conversion device: an output terminal of a common converter cell in a J-numbered stage is connected, together with output terminals of common converter cells of the other two phases, to common lines; an output terminal of an independent converter cell in a K-numbered stage is connected to independent lines independently of converter cells of the other two phases; and a plurality of switches comprise a common switch for switching the connection relationship between the common lines and DC buses, and an independent switch for switching the connection relationship between the independent lines and DC buses.
    Type: Application
    Filed: May 7, 2021
    Publication date: February 1, 2024
    Inventors: Akira KIKUCHI, Akihiko KANOUDA
  • Patent number: 11807679
    Abstract: The purpose of the present invention is to provide an anti-CKAP4 monoclonal antibody that inhibits the binding of DKK1 and CKAP4 and exhibits an exceptional antitumor effect. Provided is an anti-CKAP4 monoclonal antibody that recognizes at least part of the 451-455 region, at least part of the 481-485 region, at least part of the 502-510 region, at least part of the 503-524 region and at least part of the 585-590 region, or at least part of the 585-592 region of the amino acid sequence (amino acid sequence of CKAP4) represented by SEQ ID NO:1 as an epitope, the anti-CKAP4 monoclonal antibody effectively inhibiting the binding of DKK1 and CKAP4, the activation of AKT of S2-CP8 cells, and the proliferative ability of S2-CP8 cells or the migratory ability of S2-CP8 cells, and exhibiting an exceptional antitumor effect.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: November 7, 2023
    Assignee: OSAKA UNIVERSITY
    Inventors: Akira Kikuchi, Katsumi Fumoto, Hirokazu Kimura
  • Publication number: 20220249538
    Abstract: The purpose of the present invention is to provide a novel tumor treatment agent. In GREB1-positive tumors that do not exhibit sex hormone sensitivity, GREB1 is a downstream target gene of the Wnt/?-catenin signal. Through the use as an active ingredient of a substance that can inhibit GREB1 expression, the growth of GREB1-positive tumor cells that do not exhibit sex hormone sensitivity can be effectively inhibited and such a tumor can be treated.
    Type: Application
    Filed: May 22, 2020
    Publication date: August 11, 2022
    Inventors: Akira Kikuchi, Shinji Matsumoto, Taku Yamamichi
  • Publication number: 20220231615
    Abstract: A secondary magnetic excitation generator-motor device that inputs a first ignition pulse command to a three-level NPC power converter such that a detected excitation current value corresponds with an excitation current command value, the secondary magnetic excitation generator-motor device having a function of identifying a first phase, a second phase, or a third phase in descending order of a current absolute value, wherein a pulse switch to output an ignition pulse command to the three-level NPC power converter switches the ignition pulse command to the second ignition pulse command when a current absolute value exceeds a set overcurrent level 1, and switches the ignition pulse command to the first ignition pulse command when current absolute values for three phases are all equal to or smaller than a set overcurrent level 2.
    Type: Application
    Filed: August 8, 2019
    Publication date: July 21, 2022
    Inventors: Akira BANDO, Hironari KAWAZOE, Akira KIKUCHI
  • Patent number: 11293007
    Abstract: A method for producing a Wnt protein-afamin complex, the method comprising the steps of culturing Wnt protein-expressing cells in a culture medium containing a purified afamin or a recombinant afamin or co-culturing Wnt protein-expressing cells and recombinant afamin-expressing cells or culturing cells expressing both a Wnt protein and afamin; obtaining the culture supernatant; and optionally performing affinity purification to obtain the Wnt protein-afamin complex from the culture supernatant.
    Type: Grant
    Filed: September 10, 2019
    Date of Patent: April 5, 2022
    Assignee: OSAKA UNIVERSITY
    Inventors: Junichi Takagi, Emiko Mihara, Akira Kikuchi
  • Publication number: 20210317459
    Abstract: The purpose of the present invention is to provide an antisense oligonucleotide that targets an ARL4C molecule and exerts an antitumor effect in vivo, and a nucleic acid drug using the antisense oligonucleotide. An antisense oligonucleotide that has a base sequence consisting of at least 10 consecutive bases contained in the base sequence represented by SEQ ID NO: 1. This antisense oligonucleotide targets an ARL4C molecule and thus can inhibit the expression of ARL4C in a tumor cell in vitro and suppress the migration and proliferation thereof. When systemically administered, moreover, the antisense oligonucleotide can exert an excellent antitumor effect in vivo too.
    Type: Application
    Filed: September 4, 2019
    Publication date: October 14, 2021
    Inventors: Akira KIKUCHI, Shinji MATSUMOTO, Satoshi OBIKA, Yuya KASAHARA, Takumi FUKUMOTO
  • Patent number: 11088569
    Abstract: The purpose of the present invention is to provide a power flow monitoring device for a power system, a power system stabilization device, and a power flow monitoring method for a power system, which are highly reliable and accurate.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: August 10, 2021
    Assignee: Hitachi, Ltd.
    Inventors: Yuki Tsujii, Kenedward Kawakita, Masatoshi Kumagai, Masahiro Watanabe, Akira Kikuchi
  • Patent number: 10873273
    Abstract: An apparatus includes: an inverter converting generated power of renewable energy resources to predetermined alternating-current power for output to a power transmission network; a PWM control unit controlling the inverter; a first detecting unit detecting the input voltage and current to the inverter; a second detecting unit detecting the output voltage, current, and frequency of the inverter; a power change deciding unit calculating the input and output powers of the inverter and the difference therebetween from the voltage and current of each of the input and output detected by the detecting units, and calculating a correction output power command with reference to an output power command; and a virtual synchronous inertia control unit calculating a virtual inertia characteristic based on the voltage, current, and frequency of the output detected by the second detecting unit and the correction output power command, and outputting a reference command to a PWM control unit.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: December 22, 2020
    Assignee: Hitachi, Ltd.
    Inventors: Chia Tse Lee, Akira Kikuchi
  • Publication number: 20200377580
    Abstract: The purpose of the present invention is to provide an anti-CKAP4 monoclonal antibody that inhibits the binding of DKK1 and CKAP4 and exhibits an exceptional antitumor effect. Provided is an anti-CKAP4 monoclonal antibody that recognizes at least part of the 451-455 region, at least part of the 481-485 region, at least part of the 502-510 region, at least part of the 503-524 region and at least part of the 585-590 region, or at least part of the 585-592 region of the amino acid sequence (amino acid sequence of CKAP4) represented by SEQ ID NO:1 as an epitope, the anti-CKAP4 monoclonal antibody effectively inhibiting the binding of DKK1 and CKAP4, the activation of AKT of S2-CP8 cells, and the proliferative ability of S2-CP8 cells or the migratory ability of S2-CP8 cells, and exhibiting an exceptional antitumor effect.
    Type: Application
    Filed: September 26, 2018
    Publication date: December 3, 2020
    Inventors: Akira KIKUCHI, Katsumi FUMOTO, Hirokazu KIMURA